← Back to startup directory

Cerentry Bio

Cerentry has developed a proprietary brain shuttle designed to enable transport of systemically administered therapeutics across the brain’s protective barriers and deliver drugs to the brain.

Brain disorders are prevalent and impact billions of people across the globe. They pose a major health burden. Despite advances, treatments remain limited due to the brain barriers that prevent therapeutic agents from reaching the brain.

Copenhagen

News about Cerentry Bio

No news stories yet

Published stories about this company will appear here.

×Close